International Clinical Trials day 2017
Sat 20th May, 2017
National Waterfront Museum Swansea SA1 3RD
International Clinical Trials day is celebrated around the world on or near May 20 each year in order to celebrate the day that James Lind started what is often considered the first randomized clinical trial aboard a ship on May 20, 1747. Read more about James Lind below
DRU Cymru’s celebration of International Clinical Trials day will take place in the National Waterfront Museum Swansea on Saturday 20th May. A number of Centres and Units funded by Welsh Government through Health and Care Research Wales will be promoting Clinical Trials with information, activities and demonstrations.
SCURVY ABOARD THE HMS SALISBURY!
May 1747. The HMS Salisbury of Britain’s Royal Navy fleet patrols the English Channel at a time when scurvy is thought to have killed more British seamen than French and Spanish arms.
Aboard this ship, surgeon mate James Lind, a pioneer of naval hygiene, conducts what many refer to as the first clinical trial.
Acting on a hunch that scurvy was caused by putrefaction of the body that could be cured through the introduction of acids, Lind recruited 12 men for his “fair test.”
From The James Lind Library:
Without stating what method of allocation he used, Lind allocated two men to each of six different daily treatments for a period of fourteen days. The six treatments were: 1.1 litres of cider; twenty-five millilitres of elixir vitriol (dilute sulphuric acid); 18 millilitres of vinegar three times throughout the day before meals; half a pint of sea water; two oranges and one lemon continued for six days only (when the supply was exhausted); and a medicinal paste made up of garlic, mustard seed, dried radish root and gum myrrh.
Those allocated citrus fruits experienced “the most sudden and good visible effects,” according to Lind’s report on the trial.
Though Lind, according to The James Lind Library, might have left his readers “confused about his recommendations” regarding the use of citrus in curing scurvy, he is “rightly recognized for having taken care to ‘compare like with like’, and the design of his trial may have inspired” and informed future clinical trial design.